Hostname: page-component-745bb68f8f-b95js Total loading time: 0 Render date: 2025-01-11T00:49:23.070Z Has data issue: false hasContentIssue false
  • English
  • Français

Drug defaulting by patients on long-acting phenothiazines

Published online by Cambridge University Press:  09 July 2009

D. A. W. Johnson  and
Hugh Freeman
D. A. W. Johnson
Affiliation:
From the University Hospital of South Manchester, Solford
Hugh Freeman
Affiliation:
Hope Hospital, Solford
Get access Rights & Permissions [Opens in a new window]

Synopsis

This survey investigates drug defaulting by schizophrenic patients on a regime of long-term medication with injections of long-acting phenothiazines (LAP). Although the frequency of discontinuing LAP was appreciably less than reported in most surveys on oral medication, it remained a problem. An analysis of the reasons for patients discontinuing LAP identified several causes: patient-refusal, side-effects, failure of administration of the regime, and patients losing contact with the medical services by moving to other districts.

Type
Research Article
Information
Psychological Medicine , Volume 3 , Issue 1 , February 1973 , pp. 115 - 119
Copyright
Copyright © Cambridge University Press 1973

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Crumpton, N. E. (1968). The role of drugs in maintaining patients in the community. In The Treatment of Mental Disorders in the Community, pp. 15–24. Edited by Daniel, G. R. and Freeman, H. L.. Baillière: London.Google Scholar
Curry, S. H., Davis, J. M., Janowsky, D. S., and Marshall, J. H. L. (1970). Factors affecting chlorpromazine plasma levels in psychiatric patients. Archives of General Psychiatry, 22, 209–215.CrossRefGoogle ScholarPubMed
de Alarc´n, R., and Carney, M. W. P. (1969). Severe depressive mood changes following slow-release intramuscular fluphenazine injection. British Medicai Journal, 3, 564–567.CrossRefGoogle Scholar
Denham, J., and Adamson, L. (1971). The contribution of fluphenazine enanthate and decanoate in the prevention of readmission of schizophrenic patients. Acta Psychiatrica Scandinavica, 47, 420–430.CrossRefGoogle ScholarPubMed
Freeman, H. L. (1971). Long acting tranquillisers in schizophrenia. Journal of Specialist Medicine, Psychiatry and Neurology, 2, No. 7, 4–8.Google Scholar
Freeman, H. L., and Mountney, G. (1967). Towards a community mental health service, 1954–1965. In New Aspects of the Mental Health Services, pp. 750–759. Edited by Freeman, H. L., and Farndale, J.. Pergamon Press: Oxford.Google Scholar
Freeman, H. L., and Johnson, D. A. W. (1970). Progress to community care in an English city. Pakistan Medical Forum, 5, 25–34.Google Scholar
Hare, E. H., and Wilcox, D. R. C. (1967). Do psychiatric in-patients take their pills? British Journal of Psychiatry, 113, 1435–1439.CrossRefGoogle ScholarPubMed
Johnson, D. A. W. (1971a). Dangers of fluphenazine. British Journal of Psychiatry, 118, 376–377.CrossRefGoogle ScholarPubMed
Johnson, D. A. W. (1971b). Fluphenazine. Journal of the Royal College of General Practitioners, 21, 304–305.Google Scholar
Johnson, D. A. W. (1971c). Treatment of depression in general practice: Unpublished M.Sc. Thesis: University of Manchester.Google Scholar
Johnson, D. A. W., and Freeman, H. L. (1972). Long-acting tranquillizers. The Practitioner, 208, 395–400.Google ScholarPubMed
Leff, J. P., and Wing, J. K. (1971). Trial of maintenance therapy in schizophrenia. British Medical Journal, 3, 599–604.CrossRefGoogle ScholarPubMed
Ley, J. P., and Spelman, M. S. (1967). Communicating with the Patient. Staples Press: London.Google Scholar
Renton, C. A., Affleck, J. W., Carstairs, G. M., and Forrest, A. D. (1963). A follow-up of schizophrenic patients in Edinburgh. Acta Psychiatrica Scandinavica, 39, 548–581.CrossRefGoogle ScholarPubMed
Scarpitti, F. R., Lefton, M., Dinitz, S., and Pasamanick, B. S. L. (1964). Problems in a home care study for Schizophrenics. Archives of General Psychiatry, 10, 143–154.CrossRefGoogle Scholar